Stallergenes Greer

At Stallergenes Greer, we’re inspired by the impactful work of the Stallergenes Greer Foundation and the contribution of renowned international experts like Dr. Alessandro Fiocchi, Director of Allergy at Pediatric Hospital Bambino Gesù in Rome. Don’t miss the Foundation’s latest video featuring Dr. Fiocchi’s thoughts on the latest edition of the Science Awards for Allergy and the vital role of encouraging innovation in food and respiratory allergy research. A big thank you to the Stallergenes Greer Foundation for fostering innovation in allergy care! #InnovationInAllergy #AllergyResearch #ScienceAwardsForAllergy

Scratching, sneezing, licking, or chewing, if your pet is showing intense or ongoing behaviors like these, it could be more than just a quirky habit. Allergies in cats and dogs are more common than you might think and can impact their well-being—and yours. Allergies occur when a pet’s immune system overreacts to everyday elements like food, environmental factors, and/or flea bites. Left untreated, these allergies can lead to lasting discomfort, health complications, and poor quality of life. That’s why timely diagnosis and treatment are essential. With over 40 years of expertise in the veterinary field, Stallergenes Greer proudly supports veterinarians and pet parents in the U.S with USDA-licensed allergen extracts and immunotherapy solutions to help pets suffering from allergies. Learn more at https://lnkd.in/ge8M7NJr Because every wag, purr, or cuddle deserves to be allergy-free. #PetGetsAllergies #VeterinaryCare #CareBeyondAllergy #VeterinaryDermatology

At Stallergenes Greer, we are fully committed to advancing diversity, equity and inclusion in the workplace and building a supportive environment. As part of our ongoing efforts to promote DE&I, we once again participated in the European Week for the Employment of People with Disabilities, and organised a series of initiatives to raise awareness and tackle everyday challenges faced by persons with disabilities. For this 28th edition, Stallergenes Greer was privileged and honoured to welcome Gaël Rivière, Gold Medalist in Blind Football at the Paris 2024 Paralympic Games. During his conference, Gaël Rivière shared his experience and insights on inclusion, disability, handling pressure, and achieving success through teamwork. Like Gaël Rivière, all the athletes who participated in the Paris 2024 Olympic and Paralympic Games, demonstrated determination, perseverance, and an extraordinary ability to surpass themselves. Athletes inspire us and prove that every challenge can be an opportunity to excel and push boundaries. Like them, we can turn obstacles into strengths. By building a culture of inclusion, mutual respect and empowerment, we can contribute to shaping a world where each individual, regardless of his or her differences, can thrive.   #Disability #SEEPH24 #Inclusion #ParalympicGamesParis2024 #GaëlRivière #HandiEM #DiversityEquityInclusion #CareBeyondAllergy

On November 29 and 30 in Madrid (Spain), Stallergenes Greer brought together more than 40 experts and healthcare professionals from Europe and beyond for an event aimed at shaping the future of #allergy personalised care and patient empowerment. Three plenary sessions were led by renowned external experts: - Supporting personalised care thanks to molecular diagnosis, by Dr. Davide Caimmi, Paediatrician and Allergist, Pneumology and Addictology, University Hospital of Montpellier, France, - Improving life for patients with peanut allergy through better diagnosis and management, by Dr. Pablo Rodríguez del Río, Allergologist at the Infantil Niño Jesús University Paediatric Hospital, Madrid (Spain), - Increasing AIT compliance by empowering allergic patients in their care, by Oliver Prof. Dr. PFAAR, Head of the Section Rhinology and Allergy, ORL-Department, University Hospital Marburg, Philipps-Universität Marburg (Germany). Each plenary session was followed by an interactive Journal Club, which fostered the active participation of attendees and many exchanges. Three practical workshops aimed at expanding the sharing of ideas on how to best optimise communication, leverage data, and translate insights into practice also took place. Stallergenes Greer would like to express a sincere thank you to all participants and speakers for their invaluable contributions. Together, we're driving the future of allergy care forward. #HealthcareInnovation #MolecularDiagnosis #AllergyCare #Collaboration #AllergenImmunotherapy #Training #AllergyWeTakeItPersonally

CHMP issues positive opinion for the extensions of indication of Palforzia® for the treatment of toddlers with confirmed peanut allergy.   Stallergenes Greer announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) provided a positive opinion for the extension of the existing indication for Palforzia® (defatted powder of Arachis hypogaea L., semen (peanuts)) to the treatment of toddlers (ages 1 to 3) with a confirmed diagnosis of peanut allergy. If the extension indication is granted by the European Commission, Palforzia® will become the first EMA approved oral immunotherapy (OIT) treatment for toddlers living with confirmed peanut allergy.   “The positive recommendation of Palforzia® marks a significant step forward for younger children with peanut allergy, as well as for their families. This milestone builds on Stallergenes Greer’s long-standing commitment to delivering innovative solutions for the benefit of allergy sufferers,” says Elena Rizova, Chief Medical Officer, Stallergenes Greer.   If granted, the marketing authorisation would cover all 27 European member states and the three European Economic Area states (Iceland, Liechtenstein and Norway). In July 2024, the U.S. Food and Drug Administration (FDA) approved the extension indication of Palforzia® for use in toddlers.   Read the full press release here: https://lnkd.in/es2-h5GW  

Stallergenes Greer was delighted to participate in the FAAM-EUROBAT 2024 (Food Allergy and Anaphylaxis Meeting, and European Consortium on Application of Flow Cytometry in Allergy) congress in Athens (Greece) on November 21-23. Stallergenes Greer proudly sponsored a scientific symposium titled "Navigating the Complexities of Peanut Allergy in Toddlers." Moderated by Katherine Anagnostou, MD, PhD, Director, Food Immunotherapy Program, Texas Children’s Hospital, Professor of Pediatric Allergy, Baylor College of Medicine (US), the session offered a multidisciplinary exploration of the main aspects of #PeanutAllergy management, aligning with the latest EAACI guidelines on IgE-mediated food allergy:   ·        Ass. Prof. Dr. Audrey Dunn Galvin, Programme Director at University College Cork and Research Fellow at the Department of Paediatrics and Child Health, Cork University Hospital (Ireland), examined the psychological burden of peanut allergies on toddlers and their families, highlighting the need for holistic approaches to support emotional well-being. ·        Prof. Helen Brough, Consultant in Paediatric Allergy and Clinical Immunology and Professor at King’s College London (UK), presented the benefits of early management of food allergies, emphasising how immune plasticity in toddlers can reshape allergic responses. ·        Ass. Prof. Dr. Katharina Blümchen, Consultant at the Dept. of Pediatrics, Division of Pneumology, Allergology, Infectious Diseases and Gastroenterology, at the University Medicine of Frankfurt, shared pivotal findings on the safety and efficacy of standardised peanut oral immunotherapy (OIT), demonstrating a favorable benefit-risk profile in children aged 1–3 years. A heartfelt thank you to our speakers for their insights and to all attendees for their active participation.    #FAAMEUROBAT2024 #EAACI #FoodAllergy #OralImmunotherapy #AllergenImmunotherapy #AllergyWeTakeItPersonally

𝐒𝐭𝐚𝐥𝐥𝐞𝐫𝐠𝐞𝐧𝐞𝐬 𝐆𝐫𝐞𝐞𝐫 𝐬’𝐞𝐧𝐠𝐚𝐠𝐞 𝐚𝐜𝐭𝐢𝐯𝐞𝐦𝐞𝐧𝐭 𝐞𝐧 𝐟𝐚𝐯𝐞𝐮𝐫 𝐝𝐞 𝐥𝐚 𝐝𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐞́ 𝐞𝐭 𝐝𝐞 𝐥’𝐢𝐧𝐜𝐥𝐮𝐬𝐢𝐨𝐧 ! Stallergenes Greer s’est mobilisé à nouveau en participant à la 28ème semaine européenne sur l’emploi des personnes handicapées en proposant plusieurs actions de sensibilisation : - Une conférence animée par Gaël Rivière, Médaillé d’Or PARIS 2024 au cécifoot, qui a trouvé les mots justes pour évoquer son parcours, le handicap, la persévérance,  la détermination et incarner des valeurs fortes. 𝑁𝑜𝑢𝑠 𝑙𝑒 𝑟𝑒𝑚𝑒𝑟𝑐𝑖𝑜𝑛𝑠 𝑐ℎ𝑎𝑙𝑒𝑢𝑟𝑒𝑢𝑠𝑒𝑚𝑒𝑛𝑡 𝑝𝑜𝑢𝑟 𝑠𝑎 𝑝𝑟𝑒́𝑐𝑖𝑒𝑢𝑠𝑒 𝑖𝑛𝑡𝑒𝑟𝑣𝑒𝑛𝑡𝑖𝑜𝑛. - Un DuoDay qui a permis à Yann, collaborateur de Fondation des Amis de l'Atelier, de passer une journée à nos côtés et de découvrir nos métiers et le parcours qui s’offrent à tous, quelque soit la situation de handicap.   - Une collecte de bouchons pour l’Association Les Bouchons d'Amour dans le but de contribuer à l’acquisition de matériel pour les personnes en situation de handicap. - Une Web-conférence et la projection de vidéos de sensibilisation, en partenariat avec HandiEM - Handicap Entreprises du Médicament - Un jeu concours sur la thématique du handicap, faisant le lien avec les jeux paralympiques de cet été. Ensemble, nous pouvons construire un monde professionnel inclusif et riche d’une diversité sous toutes ses formes.  #StallergenesGreer #Handicap #SEEPH24 #Inclusion #Diversité

"I know that every vial I inspect matters to our patients and allows them to live a normal life,” Erica Wallace, Acceptable Quality Limit Supervisor. Erica works at Stallergenes Greer’s Lenoir (NC). She is a pillar of quality control and ensures that our products maintain consistent quality standards. Every day, Stallergenes Greer colleagues across the globe work together to deliver safe, efficient, and high-quality allergen immunotherapy treatments to improve the quality of life of patients like Justin who suffer from respiratory, food or insect venom allergy. #AllergenImmunotherapy #AllergyWeTakeItPersonally #RespiratoryAllergy #FoodAllergy #InsectVenomAllergy

We are proud to highlight the inspiring initiative taken by our teams in the United States during their recent Day of Service. At Stallergenes Greer, our mission extends beyond delivering solutions. Thank you to everyone involved for embodying the values of care, engagement, and responsibility that drive us forward! #CorporateSocialResponsibility #CareBeyondAllergy #DayOfService

Halloween is almost here in many countries! This week millions of excited children will be stomping the streets in search of treats. Help make sure they enjoy their evening by providing fun, non-food options such as toys, glow sticks and stickers. It might be tempting to trust food labels stating “allergy-free” options, but remember - while the top 9 allergens account for over 90% of reactions, there are over 200 reported allergens, and because of this, there really is no such thing as “allergy-free” candy¹. To learn more about creating a safe Halloween for all children, you can visit FARE’s page on Candy Facts. Let’s keep those incoming trick-or-treaters safe! #TreatSafe #AllergyAwareness #Halloween #FoodAllergies 1. https://lnkd.in/e7trfaD6